Erectile Dysfunction.
Cardiac disease
Erectile dysfunction
Phosphodiesterase 5 inhibitor medication
Journal
Primary care
ISSN: 1558-299X
Titre abrégé: Prim Care
Pays: United States
ID NLM: 0430463
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
entrez:
30
4
2019
pubmed:
30
4
2019
medline:
7
6
2019
Statut:
ppublish
Résumé
Erectile dysfunction is a common condition. Many men do not self-report erectile dysfunction symptoms; thus, physicians must ask about sexual health and function to elicit concerns. Although the impact of untreated erectile dysfunction on quality of life should prompt physicians to ask about symptoms, so should the presence of cardiac and metabolic disease. Diagnosis of erectile dysfunction is made in the primary care office, and patients may be treated with oral, intraurethral, or intracavernosal medications; vacuum devices; or penile prosthesis. Treatment should be guided by patient preference with a goal of improving quality of life and mitigating chronic disease risk.
Identifiants
pubmed: 31030826
pii: S0095-4543(19)30009-0
doi: 10.1016/j.pop.2019.02.006
pii:
doi:
Substances chimiques
Phosphodiesterase 5 Inhibitors
0
Vasodilator Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
249-255Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.